CSS LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$989K Buy
+16,300
New +$950K 0.05% 337
2024
Q2
Sell
-5,000
Closed -$271K 904
2024
Q1
$271K Sell
5,000
-15,000
-75% -$764K 0.02% 591
2023
Q4
$1.03M Buy
+20,000
New +$1.05M 0.06% 240
2022
Q3
Sell
-72,500
Closed -$5.58M 1059
2022
Q2
$5.58M Buy
+72,500
New +$5.52M 0.23% 93
2022
Q1
Sell
-7,000
Closed -$437K 1175
2021
Q4
$437K Hold
7,000
0.02% 691
2021
Q3
$414K Hold
7,000
0.02% 697
2021
Q2
$465K Hold
7,000
0.02% 643
2021
Q1
$441K Hold
7,000
0.02% 608
2020
Q4
$434K Buy
+7,000
New +$430K 0.02% 492
2020
Q1
Sell
-22,100
Closed -$1.41M 631
2019
Q4
$1.41M Buy
+22,100
New +$1.27M 0.08% 207

Other funds holding BMY

CSS LLC's BMY Position: Q1 2026 in Review

CSS LLC reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $345K and leaving 24,100 shares worth $1.46M. The position accounts for 0.07% of the portfolio, ranked #216.

CSS LLC first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $3.27M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • CSS LLC held 24,100 shares of Bristol-Myers Squibb worth $1.46M as of Q1 2026.
  • CSS LLC sold 5,920 Bristol-Myers Squibb shares in Q1 2026, an estimated $345K.
  • Bristol-Myers Squibb made up 0.07% of CSS LLC's portfolio in Q1 2026, its #216 holding.
  • CSS LLC first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
  • CSS LLC's Bristol-Myers Squibb position peaked at $3.27M in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on CSS LLC's 13F filing for Q1 2026, filed 15 May 2026.